These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7433916)

  • 1. Prevalence of antibody against hepatitis A in Sweden in relation to age and type of community.
    Weiland O; Berg JV; Böttiger M; Lundbergh P
    Scand J Infect Dis; 1980; 12(3):171-4. PubMed ID: 7433916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antibody to hepatitis A in Iceland in relation to age, sex, and number of notified cases of hepatitis.
    Briem H; Weiland O; Fridriksson I; Berg R
    Am J Epidemiol; 1982 Sep; 116(3):451-5. PubMed ID: 7124712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A immunity in the Swedish population. A study of the prevalence of markers in the Swedish population.
    Böttiger M; Christenson B; Grillner L
    Scand J Infect Dis; 1997; 29(2):99-102. PubMed ID: 9181642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased occurrence of hepatitis A with cyclic outbreaks among drug addicts in a Swedish community.
    Widell A; Hansson BG; Moestrup T; Nordenfelt E
    Infection; 1983; 11(4):198-200. PubMed ID: 6618674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups.
    Frösner GG; Papaevangelou G; Bütler R; Iwarson S; Lindholm A; Couroucé-Pauty A; Haas H; Deinhardt F
    Am J Epidemiol; 1979 Jul; 110(1):63-9. PubMed ID: 463865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of hepatitis A virus (HAV) infection in rural Liberia.
    Prince AM; Brotman B; Richardson L; White T; Pollock N; Riddle J
    J Med Virol; 1985 Apr; 15(4):421-8. PubMed ID: 3981150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and molecular analysis of hepatitis A, B and C in a semi-urban and rural area of Crete.
    Drositis I; Bertsias A; Lionis C; Kouroumalis E
    Eur J Intern Med; 2013 Dec; 24(8):839-45. PubMed ID: 23988264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin prophylaxis against hepatitis A among Swedish UN soldiers in an endemic region.
    Weiland O; Berg JV; Bäck E; Lundbergh P
    Infection; 1979; 7(5):223-5. PubMed ID: 511340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tourist hepatitis, antibodies to hepatitis A virus and immune serum globulin prophylaxis.
    Iwarson S; Frösner G; Norkrans G
    Infection; 1978; 6(6):257-8. PubMed ID: 215556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sero-prevalence of viral hepatitis A in a district of Sri Lanka: a community based cross-sectional study.
    Ariyarathna N; Abeysena C
    BMC Infect Dis; 2019 May; 19(1):443. PubMed ID: 31113369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis A of children. Seroepidemiological study among French urban population (author's transl)].
    Drucker J; Coursaget P; Maupas P; Nivet H; Grenier B; Gerety R
    Nouv Presse Med; 1979 May; 8(21):1735-8. PubMed ID: 221882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changed epidemiology of hepatitis A infection in Scandinavia.
    Iwarson S; Frösner G; Lindholm A; Norkrans G
    Scand J Infect Dis; 1978; 10(2):155-6. PubMed ID: 209535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.
    Wong KH; Liu YM; Ng PS; Young BW; Lee SS
    J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution of anti-HAV in a population sample from Puglia].
    Angarano G; Pastore G; Buongiorno R; Dentico P; Ruggiero D; Laddago V; Lapedota E; Schiraldi O
    Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1147-52. PubMed ID: 553531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of anti-HAV in different population sectors in Lebanon: a comparative seroepidemiologic study.
    Shamma'a MH; Abu-Samra S; Salameh V; Nassar NT
    Int J Epidemiol; 1982 Dec; 11(4):406-9. PubMed ID: 6984029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of anti-HAV antibodies in selected groups of children].
    Ryszkowska A; Gładysz A; Inglot M; Molin I
    Przegl Epidemiol; 2000; 54(3-4):375-83. PubMed ID: 11349601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to hepatitis A virus among working professionals in Poland - Results of a 3-year serological survey 2013-2015.
    Juszczyk G; Czerw AI; Walewska-Zielecka B; Mikos M; Banaś T; Deptała A; Ślusarczyk J
    Ann Agric Environ Med; 2018 Sep; 25(3):572-575. PubMed ID: 30260171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.
    Joshi N; Yr NK; Kumar A
    Trop Gastroenterol; 2000; 21(2):63-5. PubMed ID: 10881625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of anti-HAV and anti-HEV antibodies in Konya, Turkey.
    Atabek ME; Fýndýk D; Gulyuz A; Erkul I
    Health Policy; 2004 Mar; 67(3):265-9. PubMed ID: 15036814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibody to hepatitis A virus in a Canadian Inuit community.
    Minuk GY; Waggoner JG; Jernigan R; Nicolle LE; Postl B; Hoofnagle JH
    Can Med Assoc J; 1982 Nov; 127(9):850-2. PubMed ID: 7139503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.